# PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN SVT

> **NCT03299517** · PHASE4 · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Arrhythmias Ventricular

## Interventions

- **DRUG:** Antiarrythmic Drugs
- **DRUG:** Antiarrhythmic drugs

## Key facts

- **NCT ID:** NCT03299517
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-02
- **Primary completion:** 2019-08-02
- **Final completion:** 2022-08-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03299517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03299517, "PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN SVT". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03299517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*